123 related articles for article (PubMed ID: 10667222)
1. Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells.
Carruba G; Cervello M; Miceli MD; Farruggio R; Notarbartolo M; Virruso L; Giannitrapani L; Gambino R; Montalto G; Castagnetta L
Ann N Y Acad Sci; 1999; 886():212-6. PubMed ID: 10667222
[No Abstract] [Full Text] [Related]
2. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Jpn J Cancer Res; 1999 Dec; 90(12):inside front cover. PubMed ID: 10665642
[No Abstract] [Full Text] [Related]
3. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.
Cui J; Zhou XD; Liu YK; Tang ZY; Zile MH
World J Gastroenterol; 2001 Aug; 7(4):542-6. PubMed ID: 11819825
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
de La Coste A; Romagnolo B; Billuart P; Renard CA; Buendia MA; Soubrane O; Fabre M; Chelly J; Beldjord C; Kahn A; Perret C
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8847-51. PubMed ID: 9671767
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
6. [beta-catenin].
Ogawa K; Yaginuma Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():161-6. PubMed ID: 11761935
[No Abstract] [Full Text] [Related]
7. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
[TBL] [Abstract][Full Text] [Related]
9. beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.
Umeda T; Yamamoto T; Kajino K; Hino O
Int J Oncol; 2000 Jun; 16(6):1133-6. PubMed ID: 10811985
[TBL] [Abstract][Full Text] [Related]
10. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.
Harada N; Oshima H; Katoh M; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2004 Jan; 64(1):48-54. PubMed ID: 14729607
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
15. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
18. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas.
Nuruki K; Toyoyama H; Ueno S; Hamanoue M; Tanabe G; Aikou T; Ozawa M
Oncol Rep; 1998; 5(5):1109-14. PubMed ID: 9683818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]